疟疾疫苗现场试验研究进展

被引：4

作者：

曹俊

高琪

机构：

[1] 江苏省寄生虫病防治研究所,卫生部寄生虫病预防与控制技术重点实验室,江苏省寄生虫分子生物学重点实验室,江苏省寄生虫病学重点学科

来源：

中国寄生虫学与寄生虫病杂志 | 2008年 / 06期

关键词：

疟疾; 疫苗; 现场试验;

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

安全有效的疟疾疫苗可能是预防、控制疟疾的有效途径。然而,迄今为止,仍无一个安全有效的疟疾疫苗应用于现场。疟疾疫苗主要分为红前期疫苗、红内期疫苗及传播阻断疫苗,本文对这3类疫苗临床试验的进展进行综述。

引用

页码：472 / 475

页数：4

共 8 条

[1]

Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein （AMA-1） FMP2.1, adjuvanted with AS02A, in malaria-na?ve adults at the Walter Reed Army Institute of Research[J] . Mark E. Polhemus,Alan J. Magill,James F. Cummings,Kent E. Kester,Chris F. Ockenhouse,David E. Lanar,Sheetij Dutta,Arnoldo Barbosa,Lorraine Soisson,Carter L. Diggs,Sally A. Robinson,John D. Haynes,V. Ann Stewart,Lisa A. Ware,Clara Brando,Urszula Krzych,Robert A. Bowden,Joe D. Cohen

[2] Obstacles to the development of a safe and effective attenuated pre-erythrocytic stage malaria vaccine [J].

Ballou, W. Ripley .

MICROBES AND INFECTION, 2007, 9 (06) :761-766

[3] Mapping the global extent of malaria in 2005 [J].

Guerra, Carlos A. ;

Snow, Robert W. ;

Hay, Simon I. .

TRENDS IN PARASITOLOGY, 2006, 22 (08) :353-358

[4]

Malaria: New Vaccines for Old?[J] . Andrew Waters.Cell . 2006 (4)

[5]

Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial[J] . Pedro L Alonso,Jahit Sacarlal,John J Aponte,Amanda Leach,Eusebio Macete,Pedro Aide,Betuel Sigauque,Jessica Milman,Inacio Mandomando,Quique Bassat,Caterina Guinovart,Mateu Espasa,Sabine Corachan,Marc Lievens,Margarita M Navia,Marie-Claude Dubois,Clara Menendez,Filip Dubovsky,Joe Cohen,Ricardo Thompson,W

[6]

Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria[J] . Elissa M. Malkin,Anna P. Durbin,David J. Diemert,Jetsumon Sattabongkot,Yimin Wu,Kazutoyo Miura,Carole A. Long,Lynn Lambert,Aaron P. Miles,Jin Wang,Anthony Stowers,Louis H. Miller,Allan Saul.Vaccine . 2005 (24)

[7]

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial[J] . Pedro L Alonso,Jahit Sacarlal,John J Aponte,Amanda Leach,Eusebio Macete,Jessica Milman,Inacio Mandomando,Bart Spiessens,Caterina Guinovart,Mateu Espasa,Quique Bassat,Pedro Aide,Opokua Ofori-Anyinam,Margarita M Navia,Sabine Corachan,Marc Ceuppens,Marie-Claude Dubois,Marie-Ange Demoitié,Filip Dubovsky,Clara Menéndez,Nadia Tornieporth,W Ripley Ballou,Ri

[8]

Safety and immunogenicity of a three-component blood-stage malaria vaccine （MSP1, MSP2, RESA） against Plasmodium falciparum in Papua New Guinean children[J] . Blaise Genton,Fadwa Al-Yaman,Inoni Betuela,Robin F Anders,Allan Saul,Kay Baea,Mata Mellombo,Jack Taraika,Graham V Brown,David Pye,David O Irving,Ingrid Felger,Hans-Peter Beck,Thomas A Smith,Michael P Alpers.Vaccine . 2003 (1)

← 1 →